Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · Chairman and CEO | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 54.005 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 54.005 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 53.2963 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 53.2963 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.3344 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 7.9884 · Balance 65.3344 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 70.4281 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 9.5728 · Balance 70.4281 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.0639 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 11.6845 · Balance 65.0639 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 67.0809 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 13.2391 · Balance 67.0809 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 50.6104 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 19.5865 · Balance 50.6104 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 38,518 | $0.00 Strike: $83.66 | $0.00 |
DisclosureSEC source: 0001193125-25-316352 · ownership.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,518 Underlying: Common Stock · 38,518 shares Expires 2032-12-10 F3 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 6,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316352 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670,105 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314629 · ownership.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45.6923 Underlying: Common Stock · 25 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314629 · ownership.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44.693 Underlying: Common Stock · 21 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 681 | $82.93 | $56,475.33 |
DisclosureSEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,663,830 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,664,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 567 | $82.93 | $47,021.31 |
DisclosureSEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,664,486 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 00:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-314629 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,665,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 06, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 10 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34.8716 Underlying: Common Stock · 11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F10 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F10 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F10 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 06, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 553 | $84.53 | $46,745.09 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,665,032 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/6/2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 06, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,665,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 11.62 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 9 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45.8716 Underlying: Common Stock · 11.62 shares Expires not disclosed F9 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10.7112 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 8 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70.6923 Underlying: Common Stock · 10.7112 shares Expires not disclosed F8 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8.9379 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65.693 Underlying: Common Stock · 8.9379 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.9708 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80.2224 Underlying: Common Stock · 6.9708 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.9708 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80.9311 Underlying: Common Stock · 6.9708 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 04, 2025 Filed Dec 9, 2025 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.4203 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-311602 · ownership.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56.3976 Underlying: Common Stock · 3.4203 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 00:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-307161 · ownership.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · balance_after: Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 00:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 455 | $83.68 | $38,074.40 |
DisclosureSEC source: 0001193125-25-307161 · ownership.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,665,574 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 00:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-307161 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,666,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 22:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,681 | $0.00 Strike: $41.02 | $0.00 |
DisclosureSEC source: 0001193125-25-291658 · ownership.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,681 shares Expires 2025-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 22:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,681 | $41.02 | $109,974.62 |
DisclosureSEC source: 0001193125-25-291658 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,665,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 21,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 Disclosed balance after: 21,300 F1 · ownership.nature: These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 21,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,663,303 Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,684,603 Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028697 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,695,203 Read SEC document |
| September 04, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10.238 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 9 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34.2516 Underlying: Common Stock · 10.238 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9.4371 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 8 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59.9811 Underlying: Common Stock · 9.4371 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7.8747 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56.7551 Underlying: Common Stock · 7.8747 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.1418 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73.2516 Underlying: Common Stock · 6.1418 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.1418 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73.9603 Underlying: Common Stock · 6.1418 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.0132 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52.9773 Underlying: Common Stock · 3.0132 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 04, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.0944 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48.5172 Underlying: Common Stock · 2.0944 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,705,803 Read SEC document |
| September 03, 2025 Filed Sep 6, 2025 00:59 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 10,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-028513 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,716,403 Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 21:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 100,000 | $93.51 | $9,350,530.00 |
DisclosureSEC source: 0001437749-25-025775 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,727,003 F1 · price: Adoption date of referenced 10b5-1(c) plan is: 03-10-2025 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $93.03 to $94.00. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 12.2285 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.0136 Underlying: Common Stock · 12.2285 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 11.2713 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50.544 Underlying: Common Stock · 11.2713 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9.4056 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48.8804 Underlying: Common Stock · 9.4056 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7.3356 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67.1098 Underlying: Common Stock · 7.3356 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7.3356 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67.8185 Underlying: Common Stock · 7.3356 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.5993 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49.9641 Underlying: Common Stock · 3.5993 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.501 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-019157 · rdgdoc.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46.4228 Underlying: Common Stock · 2.501 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 20, 2025 Filed May 20, 2025 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,182 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 15 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,373 Underlying: Common Stock · 6,182 shares Expires 2030-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| May 20, 2025 Filed May 20, 2025 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,075 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 14 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,269 Underlying: Common Stock · 7,075 shares Expires 2029-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| May 20, 2025 Filed May 20, 2025 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,734 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 13 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,733 Underlying: Common Stock · 7,734 shares Expires 2028-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| May 20, 2025 Filed May 20, 2025 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,836 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 12 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,836 Underlying: Common Stock · 7,836 shares Expires 2027-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| May 20, 2025 Filed May 20, 2025 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,792 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-25-017883 · rdgdoc.xml · derivative · entry 11 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,792 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| May 20, 2025 Filed May 20, 2025 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 1,099 | $84.69 | $93,077.17 |
DisclosureSEC source: 0001437749-25-017883 · rdgdoc.xml · nonDerivative · entry 10 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,827,003 F6 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $84.23 to $84.88. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.